Patent · US Active

Methods for electronic analyte assaying

US9588113B2 · kind B2 · utility

1Cited by
38References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2012
Grant dateMar 7, 2017
Priority date
Expiry dateOct 4, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/203332
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An improved qualitative or semi-quantitative diagnostic test for low levels of any analyte, such as hCG, in a biological sample, such as urine. The test comprises of a test device containing reagents for the detection of the monitored analyte and an electronic reader that measures color development at a detection area of the device. The color development is converted to an electronic or digital signal. Improvements were made to the detection process to optimize the detection of a valid fluid front, increase the detection limit without compromising the reliability and accuracy of the test system, and improve the determination of test result validity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.